Seeking Alpha

Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.53 beats by $0.12. Revenue of $183.7M misses by $0.1M....

Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.53 beats by $0.12. Revenue of $183.7M misses by $0.1M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)